rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Amresh Kumar

VP Program Management

Company insider

Files Form 4 as: VP Program Management, Grace Therapeutics.

In numbers

Trades disclosed
6
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
14 Jul 2023
Last trade
28 Aug 2026
Last filed
1 Sep 2026

Companies traded

Where they are an officer
GRCE Grace TherapeuticsOfficer · Biotechnology · last 28 Aug 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
28 Aug 2026filed 1 Sep 2026GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,760 at $0.00filing
28 Aug 2026filed 1 Sep 2026GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,760 at $0.00filing
14 Apr 2025filed 16 Apr 2025GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
6 May 2024filed 10 May 2024GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,740 at $0.00filing
6 May 2024filed 8 May 2024GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,740 at $0.00filing
14 Jul 2023filed 18 Jul 2023GRCE Grace Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—42,000 at $0.00filing

Sectors

No trade we could place in a sector.

Related people

Opaleye Management Inc.10% owner · 10% owner at Grace Therapeutics, filing Form 4 there in the last year
Edward NeugeborenDirector · Director at Grace Therapeutics, filing Form 4 there in the last year
A. Brian DavisDirector · Director at Grace Therapeutics, filing Form 4 there in the last year
Vimal KavuruDirector · Director at Grace Therapeutics, filing Form 4 there in the last year
George KottayilDirector · Director at Grace Therapeutics, filing Form 4 there in the last year